Evaluating an Expressive Writing Intervention About Communicatively-Restricted Organizational Stressors

Sponsor
Santa Clara University (Other)
Overall Status
Completed
CT.gov ID
NCT01328665
Collaborator
(none)
44
1
2
14
3.1

Study Details

Study Description

Brief Summary

This project evaluates the effectiveness of an intervention sought to reduce the physical effects of stress related to those issues that individuals cannot successfully communicate with anyone about. To do this, the investigators will be implementing a writing intervention over the course of the 6-week study. The investigators will be asking all participants to complete questionnaires over the course of the study period. The investigators are also asking participants to provide a small blood sample (from a fingerstick procedure) at two times during the study as well as saliva samples during that same time. The primary research question asks if this intervention procedure is effective. The investigators are evaluating total cholesterol, high sensitivity c-reactive protein, and cortisol.

Condition or Disease Intervention/Treatment Phase
  • Other: Expressive Writing
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Evaluating an Expressive Writing Intervention About Communicatively-Restricted Organizational Stressors: A Six-Week Randomized, Controlled Trial
Study Start Date :
Apr 1, 2011
Actual Primary Completion Date :
Jun 1, 2012
Actual Study Completion Date :
Jun 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Expressive Writing

Affectionate Writing Intervention for 20 minutes per day, 2 times per week, 6 weeks.

Other: Expressive Writing
Writing intervention for cognitive appraisal of stressor.

No Intervention: No writing

Control Group -- No writing

Outcome Measures

Primary Outcome Measures

  1. Change in Lipids from baseline [Week 1 and Week 6]

    Lipid panel includes total cholesterol, High-density lipoproteins, low-density lipoprotein, and triglycerides.

  2. Change in high-sensitivity c-Reactive Protein from baseline [Week 1 and Week 6]

  3. Change in Cortisol Awakening Response from Baseline [Week 1 and Week 6]

    Measurement of Salivary Cortisol (hydrocortisone, compound-F) as a maximum difference between awakening and 30 minutes after awakening.

Secondary Outcome Measures

  1. Change in Perceived Global Stress over time [Week 1, Week 3, Week 6]

    Psychological measure of stress

  2. Change in Organizational Stress over time [Week 1, Week 3, Week 6]

    Psychological measure of stress as a function of organizational involvement.

  3. Change in Perception of Communication Restriction of Stressor over time [Week 1, Week 3, Week 6]

    Restrictedness of a communicative stressor

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 110 pounds in weight

  • Ability to fast for 8 hours prior to laboratory visit

  • Staff member at Santa Clara University

  • Certain level of inclusionary pretest stress measure

Exclusion Criteria:
  • Hepatitis

  • Endocrine Disease

  • Kidney or Liver Disease

  • Cancer (in any form)

  • Cushing's disorder

  • Rheumatological disorders

  • Respiratory Disorders

  • Diabetes

  • High blood pressure

  • Low blood pressure

  • Heart or cardiovascular problems

  • Chemotherapy

  • Current use of alpha or beta blockers, steroids, or hormone replacements

  • Pregnant and/or breastfeeding mothers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Santa Clara University, Health Center Santa Clara California United States 95053

Sponsors and Collaborators

  • Santa Clara University

Investigators

  • Principal Investigator: Justin P Boren, Ph.D., Santa Clara University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Justin P. Boren, Assistant Professor, Santa Clara University
ClinicalTrials.gov Identifier:
NCT01328665
Other Study ID Numbers:
  • SCUIRB03282011-1
First Posted:
Apr 5, 2011
Last Update Posted:
May 20, 2013
Last Verified:
May 1, 2013
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 20, 2013